News

EpiMOGRIFY, published in Cell Systems, is Mogrify®’s second platform that enables the systematic identification of epigenetic switches driving cell identity and cell maintenance.

EpiMOGRIFY enables the identification of the optimal culture conditions required to maintain cells in chemically defined media, enhancing cell conversions to support cGMP cultures and the development of scalable off-the-shelf therapies for diseases with a high unmet clinical need.

Discover high-resolution data, computational power, and novel algorithms as a means of exploring transcriptomic networks, systematically discovering the key regulatory switches driving cell identity and accelerating regenerative medicine.